Marek, Kenneth
Institute for Neurodegenerative Disorders
8 papers on CoChatORCID 0000-0002-4197-5627
Most cited papers
- Verified
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 7,653
- Verified
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsNeurology and Historical Studies
Cited by 859
- Verified
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M. (2020) · Journal of Parkinson's Disease
Parkinson's Disease Mechanisms and TreatmentsCOVID-19 and healthcare impacts
Cited by 177
- Verified
Parkinson’s progression markers initiative: a milestone-based strategy to monitor Parkinson’s disease progression
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 70
- Verified
The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease
Stephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., et al. (2019) · Journal of Parkinson’s Disease
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 46
- Verified
Displacement of Serotonin and Dopamine Transporters by Venlafaxine Extended Release Capsule at Steady State: A [123I]2β-Carbomethoxy-3β-(4-Iodophenyl)-Tropane Single Photon Emission Computed Tomography Imaging Study
Shang, Y., Gibbs, M. A., Marek, G. J., Stiger, T., Burstein, A. H., Marek, K., Seibyl, J. P., & Rogers, J. F. (2007) · Journal of Clinical Psychopharmacology
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 36
- Verified
Accelerating Parkinson’s Disease drug development with federated learning approaches
Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., et al. (2024) · npj Parkinson's Disease
Privacy-Preserving Technologies in DataParkinson's Disease Mechanisms and Treatments
Cited by 21
- Verified
Portable objective assessment of upper extremity motor function in Parkinson's disease
Chahine, L. M., Uribe, L., Hogarth, P., McNames, J., Siderowf, A., Marek, K., & Jennings, D. (2017) · Parkinsonism & Related Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free